|
BIIB
|
Biogen Idec Inc.
|
0.66%
|
US
|
NASDAQ
|
|
AMGN
|
Amgen Inc.
|
0.66%
|
US
|
NASDAQ
|
|
RXDX
|
Prometheus Biosciences, Inc.
|
0.65%
|
US
|
NASDAQ
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
0.65%
|
US
|
NASDAQ
|
|
NTRA
|
Natera, Inc.
|
0.65%
|
US
|
NASDAQ
|
|
ISEE
|
IVERIC bio, Inc.
|
0.65%
|
US
|
NASDAQ
|
|
HALO
|
Halozyme Therapeutics, Inc.
|
0.65%
|
US
|
NASDAQ
|
|
ALNY
|
Alnylam Pharmaceuticals, Inc.
|
0.65%
|
US
|
NASDAQ
|
|
CRSP
|
CRISPR Therapeutics AG
|
0.64%
|
US
|
NASDAQ
|
|
BEAM
|
Beam Therapeutics Inc.
|
0.64%
|
US
|
NASDAQ
|
|
VERV
|
Verve Therapeutics, Inc.
|
0.63%
|
US
|
NASDAQ
|
|
APLS
|
Apellis Pharmaceuticals, Inc.
|
0.63%
|
US
|
NASDAQ
|
|
VRTX
|
Vertex Pharmaceuticals Incorporated
|
0.62%
|
US
|
NASDAQ
|
|
RLAY
|
Relay Therapeutics, Inc.
|
0.62%
|
US
|
NASDAQ
|
|
PRTA
|
Prothena Corporation plc
|
0.62%
|
US
|
NASDAQ
|
|
MYOV
|
Myovant Sciences Ltd.
|
0.62%
|
US
|
NYSE
|
|
IOVA
|
Iovance Biotherapeutics, Inc.
|
0.62%
|
US
|
NASDAQ
|
|
CERE
|
Cerevel Therapeutics Holdings, Inc.
|
0.61%
|
US
|
NASDAQ
|
|
EDIT
|
Editas Medicine, Inc.
|
0.58%
|
US
|
NASDAQ
|
|
DVAX
|
Dynavax Technologies Corporation
|
0.57%
|
US
|
NASDAQ
|